MedTrace Logo

Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

NCT01412047 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2017-10-18

No results posted yet for this study

Summary

How does long term treatment with Soliris affect HAHA in PNH patients?

Conditions

Sponsors & Collaborators

  • Alexion Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Camille Bedrosian, MD · Alexion Pharmaceuticals, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States
  • Australia
  • Belgium
  • France
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01412047 on ClinicalTrials.gov